Relugolix combination therapy in European women with symptomatic uterine fibroids: a subgroup analysis from the randomized phase 3 LIBERTY pivotal trials

Volume 39, Issue 1, December 2023 .
Source: Gynecological Endocrinology - Category: Endocrinology Authors: Source Type: research
More News: Endocrinology | OBGYN | Women